In another study, Pal et al. designed an MNPs-Abs-based fluorescence spectroscopic platform to analyze ovarian cancer biomarkers [cancer antigen 125 (CA-125), β2-microglobulin (β2-M), and Apolipoprotein A1 (ApoA1)]. Here, MUC16 is linked to ovarian carcinoma.